Literature DB >> 2581446

Familial Sotos syndrome (cerebral gigantism): craniofacial and psychological characteristics.

A E Bale, M A Drum, D M Parry, J J Mulvihill.   

Abstract

Most reported cases of Sotos syndrome are sporadic, but autosomal dominant and recessive inheritance patterns have been suggested. Ascertainment of a two-generation family through a 7-year-old proposita with a learning disability allowed the relatively unbiased study of two affected relatives. Developmental delay was not pronounced in the patient's mother or sister; craniofacial characteristics at variance with the characteristic description included acrocephaly and maxillary prominence. Steepness of the anterior cranial base angle and protrusion of the middle and lower face, shown in all three patients by cephalometric radiographs, deserve further evaluation as diagnostic criteria.

Entities:  

Mesh:

Year:  1985        PMID: 2581446     DOI: 10.1002/ajmg.1320200407

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Sotos syndrome.

Authors:  T R Cole; H E Hughes
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

2.  Sotos syndrome: a study of the diagnostic criteria and natural history.

Authors:  T R Cole; H E Hughes
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

3.  Neuroblastoma in a patient with Sotos' syndrome.

Authors:  M A Nance; J P Neglia; D Talwar; S A Berry
Journal:  J Med Genet       Date:  1990-02       Impact factor: 6.318

4.  Autistic disorder in Sotos syndrome: a case report.

Authors:  J D Morrow; B Y Whitman; P J Accardo
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

Review 5.  Odontomas and supernumerary teeth: is there a common origin?

Authors:  Roberto Pippi
Journal:  Int J Med Sci       Date:  2014-11-12       Impact factor: 3.738

Review 6.  Cognition and Behaviour in Sotos Syndrome: A Systematic Review.

Authors:  Chloe Lane; Elizabeth Milne; Megan Freeth
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.